Veeva and bioforum partner with redhill biopharma to maximize value of opaganib phase 2/3 covid-19 clinical data

Veeva and bioforum partner with redhill biopharma to maximize value of opaganib phase 2/3 covid-19 clinical data.veeva systems inc - opaganib phase 2/3 study is set to enroll up to 270 patients in up to 40 clinical sites around world.
VEEV Ratings Summary
VEEV Quant Ranking